nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluoxetine—ORM1—Vismodegib—skin cancer	0.146	0.186	CbGbCtD
Fluoxetine—ORM1—Vemurafenib—skin cancer	0.115	0.147	CbGbCtD
Fluoxetine—ALB—Vismodegib—skin cancer	0.0613	0.0782	CbGbCtD
Fluoxetine—CYP1A2—Imiquimod—skin cancer	0.0529	0.0675	CbGbCtD
Fluoxetine—ALB—Vemurafenib—skin cancer	0.0485	0.0618	CbGbCtD
Fluoxetine—CYP2C19—Vismodegib—skin cancer	0.0398	0.0507	CbGbCtD
Fluoxetine—CYP2C9—Vismodegib—skin cancer	0.0331	0.0422	CbGbCtD
Fluoxetine—ABCB1—Vismodegib—skin cancer	0.0321	0.0409	CbGbCtD
Fluoxetine—CYP1A2—Vemurafenib—skin cancer	0.029	0.037	CbGbCtD
Fluoxetine—CYP3A4—Imiquimod—skin cancer	0.0277	0.0354	CbGbCtD
Fluoxetine—CYP3A4—Temozolomide—skin cancer	0.0277	0.0354	CbGbCtD
Fluoxetine—CYP2D6—Vemurafenib—skin cancer	0.0239	0.0305	CbGbCtD
Fluoxetine—CYP1A2—Dacarbazine—skin cancer	0.0222	0.0283	CbGbCtD
Fluoxetine—ALB—Fluorouracil—skin cancer	0.0218	0.0278	CbGbCtD
Fluoxetine—CYP3A4—Vismodegib—skin cancer	0.0192	0.0245	CbGbCtD
Fluoxetine—ABCB1—Dactinomycin—skin cancer	0.0169	0.0215	CbGbCtD
Fluoxetine—CYP3A4—Vemurafenib—skin cancer	0.0152	0.0194	CbGbCtD
Fluoxetine—CYP3A5—Docetaxel—skin cancer	0.0134	0.0171	CbGbCtD
Fluoxetine—CYP1A2—Fluorouracil—skin cancer	0.013	0.0166	CbGbCtD
Fluoxetine—CYP2C9—Fluorouracil—skin cancer	0.0117	0.015	CbGbCtD
Fluoxetine—ABCB1—Docetaxel—skin cancer	0.0087	0.0111	CbGbCtD
Fluoxetine—Monobenzone—TYR—skin cancer	0.00659	0.92	CrCbGaD
Fluoxetine—CYP3A4—Docetaxel—skin cancer	0.00521	0.00665	CbGbCtD
Fluoxetine—Orphenadrine—SCN10A—skin cancer	0.00057	0.0796	CrCbGaD
Fluoxetine—Leukopenia—Bleomycin—skin cancer	0.000179	0.000863	CcSEcCtD
Fluoxetine—Rhinitis—Fluorouracil—skin cancer	0.000179	0.000863	CcSEcCtD
Fluoxetine—Haemorrhage—Fluorouracil—skin cancer	0.000178	0.000861	CcSEcCtD
Fluoxetine—Dizziness—Vemurafenib—skin cancer	0.000178	0.000859	CcSEcCtD
Fluoxetine—Hypoaesthesia—Fluorouracil—skin cancer	0.000177	0.000856	CcSEcCtD
Fluoxetine—Pharyngitis—Fluorouracil—skin cancer	0.000177	0.000854	CcSEcCtD
Fluoxetine—Ataxia—Docetaxel—skin cancer	0.000175	0.000844	CcSEcCtD
Fluoxetine—Cough—Bleomycin—skin cancer	0.000174	0.000841	CcSEcCtD
Fluoxetine—Chills—Temozolomide—skin cancer	0.000174	0.000838	CcSEcCtD
Fluoxetine—Dehydration—Docetaxel—skin cancer	0.000173	0.000835	CcSEcCtD
Fluoxetine—Ill-defined disorder—Dactinomycin—skin cancer	0.000173	0.000834	CcSEcCtD
Fluoxetine—Anaemia—Dactinomycin—skin cancer	0.000172	0.000831	CcSEcCtD
Fluoxetine—Liver function test abnormal—Docetaxel—skin cancer	0.000172	0.000829	CcSEcCtD
Fluoxetine—Vomiting—Vemurafenib—skin cancer	0.000171	0.000826	CcSEcCtD
Fluoxetine—Alopecia—Temozolomide—skin cancer	0.000171	0.000826	CcSEcCtD
Fluoxetine—Dry skin—Docetaxel—skin cancer	0.00017	0.000823	CcSEcCtD
Fluoxetine—Chest pain—Bleomycin—skin cancer	0.00017	0.000821	CcSEcCtD
Fluoxetine—Myalgia—Bleomycin—skin cancer	0.00017	0.000821	CcSEcCtD
Fluoxetine—Orthostatic hypotension—Docetaxel—skin cancer	0.00017	0.00082	CcSEcCtD
Fluoxetine—Rash—Vemurafenib—skin cancer	0.00017	0.000819	CcSEcCtD
Fluoxetine—Mental disorder—Temozolomide—skin cancer	0.000169	0.000818	CcSEcCtD
Fluoxetine—Dermatitis—Vemurafenib—skin cancer	0.000169	0.000818	CcSEcCtD
Fluoxetine—Hypersensitivity—Imiquimod—skin cancer	0.000169	0.000816	CcSEcCtD
Fluoxetine—Headache—Vemurafenib—skin cancer	0.000168	0.000814	CcSEcCtD
Fluoxetine—Malnutrition—Temozolomide—skin cancer	0.000168	0.000813	CcSEcCtD
Fluoxetine—Breast disorder—Docetaxel—skin cancer	0.000168	0.000812	CcSEcCtD
Fluoxetine—Discomfort—Bleomycin—skin cancer	0.000168	0.000811	CcSEcCtD
Fluoxetine—Malaise—Dactinomycin—skin cancer	0.000168	0.000811	CcSEcCtD
Fluoxetine—Toxic epidermal necrolysis—Docetaxel—skin cancer	0.000167	0.000809	CcSEcCtD
Fluoxetine—Leukopenia—Dactinomycin—skin cancer	0.000167	0.000805	CcSEcCtD
Fluoxetine—Dysgeusia—Temozolomide—skin cancer	0.000165	0.000796	CcSEcCtD
Fluoxetine—Asthenia—Imiquimod—skin cancer	0.000165	0.000795	CcSEcCtD
Fluoxetine—Confusional state—Bleomycin—skin cancer	0.000164	0.000793	CcSEcCtD
Fluoxetine—Alanine aminotransferase increased—Docetaxel—skin cancer	0.000164	0.000792	CcSEcCtD
Fluoxetine—Anaphylactic shock—Bleomycin—skin cancer	0.000163	0.000787	CcSEcCtD
Fluoxetine—Back pain—Temozolomide—skin cancer	0.000163	0.000787	CcSEcCtD
Fluoxetine—Pruritus—Imiquimod—skin cancer	0.000162	0.000784	CcSEcCtD
Fluoxetine—Infection—Bleomycin—skin cancer	0.000162	0.000782	CcSEcCtD
Fluoxetine—Dysphagia—Docetaxel—skin cancer	0.000161	0.000776	CcSEcCtD
Fluoxetine—Nausea—Vemurafenib—skin cancer	0.00016	0.000771	CcSEcCtD
Fluoxetine—Thrombocytopenia—Bleomycin—skin cancer	0.000159	0.00077	CcSEcCtD
Fluoxetine—Arrhythmia—Fluorouracil—skin cancer	0.000159	0.000769	CcSEcCtD
Fluoxetine—Myalgia—Dactinomycin—skin cancer	0.000158	0.000765	CcSEcCtD
Fluoxetine—Bronchospasm—Docetaxel—skin cancer	0.000158	0.000763	CcSEcCtD
Fluoxetine—Tremor—Temozolomide—skin cancer	0.000158	0.000762	CcSEcCtD
Fluoxetine—Alopecia—Fluorouracil—skin cancer	0.000157	0.000761	CcSEcCtD
Fluoxetine—Diarrhoea—Imiquimod—skin cancer	0.000157	0.000758	CcSEcCtD
Fluoxetine—Discomfort—Dactinomycin—skin cancer	0.000157	0.000756	CcSEcCtD
Fluoxetine—Angina pectoris—Docetaxel—skin cancer	0.000157	0.000756	CcSEcCtD
Fluoxetine—Ill-defined disorder—Temozolomide—skin cancer	0.000156	0.000755	CcSEcCtD
Fluoxetine—Anaemia—Temozolomide—skin cancer	0.000156	0.000752	CcSEcCtD
Fluoxetine—Anorexia—Bleomycin—skin cancer	0.000155	0.00075	CcSEcCtD
Fluoxetine—Agitation—Temozolomide—skin cancer	0.000155	0.000747	CcSEcCtD
Fluoxetine—Angioedema—Temozolomide—skin cancer	0.000154	0.000743	CcSEcCtD
Fluoxetine—Pancytopenia—Docetaxel—skin cancer	0.000153	0.000737	CcSEcCtD
Fluoxetine—Hypotension—Bleomycin—skin cancer	0.000152	0.000735	CcSEcCtD
Fluoxetine—Malaise—Temozolomide—skin cancer	0.000152	0.000733	CcSEcCtD
Fluoxetine—Dizziness—Imiquimod—skin cancer	0.000152	0.000732	CcSEcCtD
Fluoxetine—Vertigo—Temozolomide—skin cancer	0.000151	0.000731	CcSEcCtD
Fluoxetine—Infection—Dactinomycin—skin cancer	0.000151	0.000729	CcSEcCtD
Fluoxetine—Leukopenia—Temozolomide—skin cancer	0.000151	0.000728	CcSEcCtD
Fluoxetine—Palpitations—Temozolomide—skin cancer	0.000149	0.000719	CcSEcCtD
Fluoxetine—Thrombocytopenia—Dactinomycin—skin cancer	0.000149	0.000718	CcSEcCtD
Fluoxetine—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000148	0.000717	CcSEcCtD
Fluoxetine—Cough—Temozolomide—skin cancer	0.000147	0.00071	CcSEcCtD
Fluoxetine—Paraesthesia—Bleomycin—skin cancer	0.000146	0.000707	CcSEcCtD
Fluoxetine—Weight increased—Docetaxel—skin cancer	0.000146	0.000706	CcSEcCtD
Fluoxetine—Convulsion—Temozolomide—skin cancer	0.000146	0.000705	CcSEcCtD
Fluoxetine—Vomiting—Imiquimod—skin cancer	0.000146	0.000704	CcSEcCtD
Fluoxetine—Weight decreased—Docetaxel—skin cancer	0.000145	0.000702	CcSEcCtD
Fluoxetine—Hypertension—Temozolomide—skin cancer	0.000145	0.000702	CcSEcCtD
Fluoxetine—Dyspnoea—Bleomycin—skin cancer	0.000145	0.000701	CcSEcCtD
Fluoxetine—Anorexia—Dactinomycin—skin cancer	0.000145	0.000699	CcSEcCtD
Fluoxetine—Rash—Imiquimod—skin cancer	0.000145	0.000698	CcSEcCtD
Fluoxetine—Dermatitis—Imiquimod—skin cancer	0.000144	0.000698	CcSEcCtD
Fluoxetine—Pneumonia—Docetaxel—skin cancer	0.000144	0.000696	CcSEcCtD
Fluoxetine—Headache—Imiquimod—skin cancer	0.000144	0.000694	CcSEcCtD
Fluoxetine—Anaemia—Fluorouracil—skin cancer	0.000143	0.000693	CcSEcCtD
Fluoxetine—Arthralgia—Temozolomide—skin cancer	0.000143	0.000692	CcSEcCtD
Fluoxetine—Myalgia—Temozolomide—skin cancer	0.000143	0.000692	CcSEcCtD
Fluoxetine—Anxiety—Temozolomide—skin cancer	0.000143	0.00069	CcSEcCtD
Fluoxetine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.000142	0.000688	CcSEcCtD
Fluoxetine—Stevens-Johnson syndrome—Docetaxel—skin cancer	0.000142	0.000686	CcSEcCtD
Fluoxetine—Discomfort—Temozolomide—skin cancer	0.000142	0.000684	CcSEcCtD
Fluoxetine—Decreased appetite—Bleomycin—skin cancer	0.000142	0.000684	CcSEcCtD
Fluoxetine—Acute coronary syndrome—Docetaxel—skin cancer	0.000141	0.000682	CcSEcCtD
Fluoxetine—Renal failure—Docetaxel—skin cancer	0.000141	0.00068	CcSEcCtD
Fluoxetine—Neuropathy peripheral—Docetaxel—skin cancer	0.00014	0.000678	CcSEcCtD
Fluoxetine—Myocardial infarction—Docetaxel—skin cancer	0.00014	0.000678	CcSEcCtD
Fluoxetine—Dry mouth—Temozolomide—skin cancer	0.00014	0.000677	CcSEcCtD
Fluoxetine—Jaundice—Docetaxel—skin cancer	0.00014	0.000675	CcSEcCtD
Fluoxetine—Stomatitis—Docetaxel—skin cancer	0.00014	0.000675	CcSEcCtD
Fluoxetine—Pain—Bleomycin—skin cancer	0.000139	0.000673	CcSEcCtD
Fluoxetine—Conjunctivitis—Docetaxel—skin cancer	0.000139	0.000673	CcSEcCtD
Fluoxetine—Leukopenia—Fluorouracil—skin cancer	0.000139	0.000671	CcSEcCtD
Fluoxetine—Confusional state—Temozolomide—skin cancer	0.000139	0.000669	CcSEcCtD
Fluoxetine—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000138	0.000669	CcSEcCtD
Fluoxetine—Anaphylactic shock—Temozolomide—skin cancer	0.000137	0.000664	CcSEcCtD
Fluoxetine—Infection—Temozolomide—skin cancer	0.000137	0.000659	CcSEcCtD
Fluoxetine—Nausea—Imiquimod—skin cancer	0.000136	0.000658	CcSEcCtD
Fluoxetine—Epistaxis—Docetaxel—skin cancer	0.000135	0.000653	CcSEcCtD
Fluoxetine—Thrombocytopenia—Temozolomide—skin cancer	0.000135	0.00065	CcSEcCtD
Fluoxetine—Convulsion—Fluorouracil—skin cancer	0.000134	0.000649	CcSEcCtD
Fluoxetine—Feeling abnormal—Bleomycin—skin cancer	0.000134	0.000648	CcSEcCtD
Fluoxetine—Skin disorder—Temozolomide—skin cancer	0.000133	0.000645	CcSEcCtD
Fluoxetine—Hyperhidrosis—Temozolomide—skin cancer	0.000133	0.000642	CcSEcCtD
Fluoxetine—Chest pain—Fluorouracil—skin cancer	0.000132	0.000638	CcSEcCtD
Fluoxetine—Myalgia—Fluorouracil—skin cancer	0.000132	0.000638	CcSEcCtD
Fluoxetine—Decreased appetite—Dactinomycin—skin cancer	0.000132	0.000638	CcSEcCtD
Fluoxetine—Fatigue—Dactinomycin—skin cancer	0.000131	0.000633	CcSEcCtD
Fluoxetine—Anorexia—Temozolomide—skin cancer	0.000131	0.000633	CcSEcCtD
Fluoxetine—Discomfort—Fluorouracil—skin cancer	0.00013	0.00063	CcSEcCtD
Fluoxetine—Pain—Dactinomycin—skin cancer	0.00013	0.000628	CcSEcCtD
Fluoxetine—Urticaria—Bleomycin—skin cancer	0.000129	0.000625	CcSEcCtD
Fluoxetine—Haemoglobin—Docetaxel—skin cancer	0.000129	0.000624	CcSEcCtD
Fluoxetine—Rhinitis—Docetaxel—skin cancer	0.000129	0.000623	CcSEcCtD
Fluoxetine—Body temperature increased—Bleomycin—skin cancer	0.000129	0.000622	CcSEcCtD
Fluoxetine—Hepatitis—Docetaxel—skin cancer	0.000129	0.000621	CcSEcCtD
Fluoxetine—Haemorrhage—Docetaxel—skin cancer	0.000129	0.000621	CcSEcCtD
Fluoxetine—Hypoaesthesia—Docetaxel—skin cancer	0.000128	0.000618	CcSEcCtD
Fluoxetine—Confusional state—Fluorouracil—skin cancer	0.000128	0.000617	CcSEcCtD
Fluoxetine—Pharyngitis—Docetaxel—skin cancer	0.000128	0.000617	CcSEcCtD
Fluoxetine—Oedema peripheral—Docetaxel—skin cancer	0.000127	0.000612	CcSEcCtD
Fluoxetine—Anaphylactic shock—Fluorouracil—skin cancer	0.000127	0.000612	CcSEcCtD
Fluoxetine—Infection—Fluorouracil—skin cancer	0.000126	0.000608	CcSEcCtD
Fluoxetine—SLC6A2—nerve—skin cancer	0.000126	0.0808	CbGeAlD
Fluoxetine—Feeling abnormal—Dactinomycin—skin cancer	0.000125	0.000605	CcSEcCtD
Fluoxetine—Musculoskeletal discomfort—Temozolomide—skin cancer	0.000125	0.000605	CcSEcCtD
Fluoxetine—HTR2A—hindlimb—skin cancer	0.000124	0.0799	CbGeAlD
Fluoxetine—Insomnia—Temozolomide—skin cancer	0.000124	0.0006	CcSEcCtD
Fluoxetine—Gastrointestinal pain—Dactinomycin—skin cancer	0.000124	0.0006	CcSEcCtD
Fluoxetine—Thrombocytopenia—Fluorouracil—skin cancer	0.000124	0.000599	CcSEcCtD
Fluoxetine—Visual impairment—Docetaxel—skin cancer	0.000124	0.000599	CcSEcCtD
Fluoxetine—Tachycardia—Fluorouracil—skin cancer	0.000124	0.000597	CcSEcCtD
Fluoxetine—Paraesthesia—Temozolomide—skin cancer	0.000123	0.000596	CcSEcCtD
Fluoxetine—Dyspnoea—Temozolomide—skin cancer	0.000123	0.000592	CcSEcCtD
Fluoxetine—Somnolence—Temozolomide—skin cancer	0.000122	0.00059	CcSEcCtD
Fluoxetine—Erythema multiforme—Docetaxel—skin cancer	0.000122	0.000587	CcSEcCtD
Fluoxetine—Dyspepsia—Temozolomide—skin cancer	0.000121	0.000584	CcSEcCtD
Fluoxetine—Anorexia—Fluorouracil—skin cancer	0.000121	0.000583	CcSEcCtD
Fluoxetine—Abdominal pain—Dactinomycin—skin cancer	0.00012	0.00058	CcSEcCtD
Fluoxetine—Body temperature increased—Dactinomycin—skin cancer	0.00012	0.00058	CcSEcCtD
Fluoxetine—Hypersensitivity—Bleomycin—skin cancer	0.00012	0.00058	CcSEcCtD
Fluoxetine—Decreased appetite—Temozolomide—skin cancer	0.000119	0.000577	CcSEcCtD
Fluoxetine—Gastrointestinal disorder—Temozolomide—skin cancer	0.000119	0.000573	CcSEcCtD
Fluoxetine—Fatigue—Temozolomide—skin cancer	0.000118	0.000572	CcSEcCtD
Fluoxetine—Hypotension—Fluorouracil—skin cancer	0.000118	0.000571	CcSEcCtD
Fluoxetine—Pain—Temozolomide—skin cancer	0.000118	0.000568	CcSEcCtD
Fluoxetine—Constipation—Temozolomide—skin cancer	0.000118	0.000568	CcSEcCtD
Fluoxetine—Asthenia—Bleomycin—skin cancer	0.000117	0.000565	CcSEcCtD
Fluoxetine—Chills—Docetaxel—skin cancer	0.000115	0.000557	CcSEcCtD
Fluoxetine—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000115	0.000557	CcSEcCtD
Fluoxetine—Pruritus—Bleomycin—skin cancer	0.000115	0.000557	CcSEcCtD
Fluoxetine—Arrhythmia—Docetaxel—skin cancer	0.000115	0.000555	CcSEcCtD
Fluoxetine—Insomnia—Fluorouracil—skin cancer	0.000115	0.000553	CcSEcCtD
Fluoxetine—Paraesthesia—Fluorouracil—skin cancer	0.000114	0.000549	CcSEcCtD
Fluoxetine—Alopecia—Docetaxel—skin cancer	0.000114	0.000549	CcSEcCtD
Fluoxetine—Feeling abnormal—Temozolomide—skin cancer	0.000113	0.000547	CcSEcCtD
Fluoxetine—Dyspnoea—Fluorouracil—skin cancer	0.000113	0.000545	CcSEcCtD
Fluoxetine—Mental disorder—Docetaxel—skin cancer	0.000113	0.000544	CcSEcCtD
Fluoxetine—Somnolence—Fluorouracil—skin cancer	0.000113	0.000544	CcSEcCtD
Fluoxetine—Gastrointestinal pain—Temozolomide—skin cancer	0.000112	0.000543	CcSEcCtD
Fluoxetine—Malnutrition—Docetaxel—skin cancer	0.000112	0.000541	CcSEcCtD
Fluoxetine—Hypersensitivity—Dactinomycin—skin cancer	0.000112	0.000541	CcSEcCtD
Fluoxetine—Dyspepsia—Fluorouracil—skin cancer	0.000111	0.000538	CcSEcCtD
Fluoxetine—Decreased appetite—Fluorouracil—skin cancer	0.00011	0.000532	CcSEcCtD
Fluoxetine—Dysgeusia—Docetaxel—skin cancer	0.00011	0.00053	CcSEcCtD
Fluoxetine—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000109	0.000528	CcSEcCtD
Fluoxetine—Urticaria—Temozolomide—skin cancer	0.000109	0.000527	CcSEcCtD
Fluoxetine—Asthenia—Dactinomycin—skin cancer	0.000109	0.000526	CcSEcCtD
Fluoxetine—Body temperature increased—Temozolomide—skin cancer	0.000109	0.000525	CcSEcCtD
Fluoxetine—Abdominal pain—Temozolomide—skin cancer	0.000109	0.000525	CcSEcCtD
Fluoxetine—Back pain—Docetaxel—skin cancer	0.000108	0.000523	CcSEcCtD
Fluoxetine—Pain—Fluorouracil—skin cancer	0.000108	0.000523	CcSEcCtD
Fluoxetine—Muscle spasms—Docetaxel—skin cancer	0.000108	0.00052	CcSEcCtD
Fluoxetine—HTR2A—appendage—skin cancer	0.000107	0.0685	CbGeAlD
Fluoxetine—Feeling abnormal—Fluorouracil—skin cancer	0.000104	0.000504	CcSEcCtD
Fluoxetine—Diarrhoea—Dactinomycin—skin cancer	0.000104	0.000502	CcSEcCtD
Fluoxetine—Vomiting—Bleomycin—skin cancer	0.000104	0.0005	CcSEcCtD
Fluoxetine—Anaemia—Docetaxel—skin cancer	0.000103	0.0005	CcSEcCtD
Fluoxetine—Rash—Bleomycin—skin cancer	0.000103	0.000496	CcSEcCtD
Fluoxetine—Dermatitis—Bleomycin—skin cancer	0.000103	0.000496	CcSEcCtD
Fluoxetine—Hypersensitivity—Temozolomide—skin cancer	0.000101	0.000489	CcSEcCtD
Fluoxetine—Urticaria—Fluorouracil—skin cancer	0.000101	0.000486	CcSEcCtD
Fluoxetine—Syncope—Docetaxel—skin cancer	0.0001	0.000485	CcSEcCtD
Fluoxetine—Leukopenia—Docetaxel—skin cancer	0.0001	0.000484	CcSEcCtD
Fluoxetine—Body temperature increased—Fluorouracil—skin cancer	0.0001	0.000483	CcSEcCtD
Fluoxetine—Palpitations—Docetaxel—skin cancer	9.89e-05	0.000478	CcSEcCtD
Fluoxetine—Asthenia—Temozolomide—skin cancer	9.86e-05	0.000476	CcSEcCtD
Fluoxetine—Loss of consciousness—Docetaxel—skin cancer	9.84e-05	0.000475	CcSEcCtD
Fluoxetine—Cough—Docetaxel—skin cancer	9.77e-05	0.000472	CcSEcCtD
Fluoxetine—Pruritus—Temozolomide—skin cancer	9.72e-05	0.00047	CcSEcCtD
Fluoxetine—Convulsion—Docetaxel—skin cancer	9.7e-05	0.000469	CcSEcCtD
Fluoxetine—Nausea—Bleomycin—skin cancer	9.68e-05	0.000467	CcSEcCtD
Fluoxetine—Hypertension—Docetaxel—skin cancer	9.67e-05	0.000467	CcSEcCtD
Fluoxetine—Vomiting—Dactinomycin—skin cancer	9.66e-05	0.000467	CcSEcCtD
Fluoxetine—Rash—Dactinomycin—skin cancer	9.58e-05	0.000463	CcSEcCtD
Fluoxetine—Myalgia—Docetaxel—skin cancer	9.53e-05	0.00046	CcSEcCtD
Fluoxetine—Chest pain—Docetaxel—skin cancer	9.53e-05	0.00046	CcSEcCtD
Fluoxetine—Arthralgia—Docetaxel—skin cancer	9.53e-05	0.00046	CcSEcCtD
Fluoxetine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	9.47e-05	0.000457	CcSEcCtD
Fluoxetine—Diarrhoea—Temozolomide—skin cancer	9.4e-05	0.000454	CcSEcCtD
Fluoxetine—Hypersensitivity—Fluorouracil—skin cancer	9.33e-05	0.000451	CcSEcCtD
Fluoxetine—Dry mouth—Docetaxel—skin cancer	9.32e-05	0.00045	CcSEcCtD
Fluoxetine—Confusional state—Docetaxel—skin cancer	9.21e-05	0.000445	CcSEcCtD
Fluoxetine—Anaphylactic shock—Docetaxel—skin cancer	9.14e-05	0.000441	CcSEcCtD
Fluoxetine—Dizziness—Temozolomide—skin cancer	9.09e-05	0.000439	CcSEcCtD
Fluoxetine—Infection—Docetaxel—skin cancer	9.08e-05	0.000438	CcSEcCtD
Fluoxetine—Nausea—Dactinomycin—skin cancer	9.02e-05	0.000436	CcSEcCtD
Fluoxetine—Shock—Docetaxel—skin cancer	8.99e-05	0.000434	CcSEcCtD
Fluoxetine—Pruritus—Fluorouracil—skin cancer	8.96e-05	0.000433	CcSEcCtD
Fluoxetine—Thrombocytopenia—Docetaxel—skin cancer	8.95e-05	0.000432	CcSEcCtD
Fluoxetine—Tachycardia—Docetaxel—skin cancer	8.92e-05	0.000431	CcSEcCtD
Fluoxetine—Skin disorder—Docetaxel—skin cancer	8.88e-05	0.000429	CcSEcCtD
Fluoxetine—Vomiting—Temozolomide—skin cancer	8.74e-05	0.000422	CcSEcCtD
Fluoxetine—Anorexia—Docetaxel—skin cancer	8.71e-05	0.000421	CcSEcCtD
Fluoxetine—Rash—Temozolomide—skin cancer	8.66e-05	0.000418	CcSEcCtD
Fluoxetine—Diarrhoea—Fluorouracil—skin cancer	8.66e-05	0.000418	CcSEcCtD
Fluoxetine—Dermatitis—Temozolomide—skin cancer	8.66e-05	0.000418	CcSEcCtD
Fluoxetine—Headache—Temozolomide—skin cancer	8.61e-05	0.000416	CcSEcCtD
Fluoxetine—Hypotension—Docetaxel—skin cancer	8.54e-05	0.000412	CcSEcCtD
Fluoxetine—Dizziness—Fluorouracil—skin cancer	8.37e-05	0.000404	CcSEcCtD
Fluoxetine—Musculoskeletal discomfort—Docetaxel—skin cancer	8.33e-05	0.000402	CcSEcCtD
Fluoxetine—Insomnia—Docetaxel—skin cancer	8.27e-05	0.000399	CcSEcCtD
Fluoxetine—Paraesthesia—Docetaxel—skin cancer	8.21e-05	0.000396	CcSEcCtD
Fluoxetine—Nausea—Temozolomide—skin cancer	8.16e-05	0.000394	CcSEcCtD
Fluoxetine—Dyspnoea—Docetaxel—skin cancer	8.15e-05	0.000394	CcSEcCtD
Fluoxetine—Somnolence—Docetaxel—skin cancer	8.12e-05	0.000392	CcSEcCtD
Fluoxetine—SIGMAR1—nipple—skin cancer	8.05e-05	0.0518	CbGeAlD
Fluoxetine—Vomiting—Fluorouracil—skin cancer	8.05e-05	0.000389	CcSEcCtD
Fluoxetine—Dyspepsia—Docetaxel—skin cancer	8.04e-05	0.000389	CcSEcCtD
Fluoxetine—Rash—Fluorouracil—skin cancer	7.98e-05	0.000386	CcSEcCtD
Fluoxetine—Dermatitis—Fluorouracil—skin cancer	7.98e-05	0.000385	CcSEcCtD
Fluoxetine—Decreased appetite—Docetaxel—skin cancer	7.94e-05	0.000384	CcSEcCtD
Fluoxetine—Headache—Fluorouracil—skin cancer	7.93e-05	0.000383	CcSEcCtD
Fluoxetine—Gastrointestinal disorder—Docetaxel—skin cancer	7.89e-05	0.000381	CcSEcCtD
Fluoxetine—Fatigue—Docetaxel—skin cancer	7.88e-05	0.000381	CcSEcCtD
Fluoxetine—Pain—Docetaxel—skin cancer	7.81e-05	0.000377	CcSEcCtD
Fluoxetine—Constipation—Docetaxel—skin cancer	7.81e-05	0.000377	CcSEcCtD
Fluoxetine—HTR2A—nerve—skin cancer	7.56e-05	0.0486	CbGeAlD
Fluoxetine—Feeling abnormal—Docetaxel—skin cancer	7.53e-05	0.000364	CcSEcCtD
Fluoxetine—Nausea—Fluorouracil—skin cancer	7.52e-05	0.000363	CcSEcCtD
Fluoxetine—Gastrointestinal pain—Docetaxel—skin cancer	7.47e-05	0.000361	CcSEcCtD
Fluoxetine—Abdominal pain—Docetaxel—skin cancer	7.22e-05	0.000349	CcSEcCtD
Fluoxetine—Body temperature increased—Docetaxel—skin cancer	7.22e-05	0.000349	CcSEcCtD
Fluoxetine—Hypersensitivity—Docetaxel—skin cancer	6.73e-05	0.000325	CcSEcCtD
Fluoxetine—Asthenia—Docetaxel—skin cancer	6.56e-05	0.000317	CcSEcCtD
Fluoxetine—Pruritus—Docetaxel—skin cancer	6.47e-05	0.000312	CcSEcCtD
Fluoxetine—HTR2A—endothelium—skin cancer	6.44e-05	0.0414	CbGeAlD
Fluoxetine—Diarrhoea—Docetaxel—skin cancer	6.25e-05	0.000302	CcSEcCtD
Fluoxetine—Dizziness—Docetaxel—skin cancer	6.04e-05	0.000292	CcSEcCtD
Fluoxetine—HTR2A—blood vessel—skin cancer	5.94e-05	0.0381	CbGeAlD
Fluoxetine—Vomiting—Docetaxel—skin cancer	5.81e-05	0.000281	CcSEcCtD
Fluoxetine—Rash—Docetaxel—skin cancer	5.76e-05	0.000278	CcSEcCtD
Fluoxetine—Dermatitis—Docetaxel—skin cancer	5.76e-05	0.000278	CcSEcCtD
Fluoxetine—Headache—Docetaxel—skin cancer	5.72e-05	0.000277	CcSEcCtD
Fluoxetine—CYP1A2—nipple—skin cancer	5.49e-05	0.0353	CbGeAlD
Fluoxetine—Nausea—Docetaxel—skin cancer	5.43e-05	0.000262	CcSEcCtD
Fluoxetine—ORM1—female reproductive system—skin cancer	4.76e-05	0.0306	CbGeAlD
Fluoxetine—SIGMAR1—mammalian vulva—skin cancer	4.7e-05	0.0302	CbGeAlD
Fluoxetine—HTR2C—female reproductive system—skin cancer	4.28e-05	0.0275	CbGeAlD
Fluoxetine—HTR2A—neck—skin cancer	4.25e-05	0.0273	CbGeAlD
Fluoxetine—SLC6A4—female reproductive system—skin cancer	4.06e-05	0.0261	CbGeAlD
Fluoxetine—ABCB1—blood vessel—skin cancer	3.89e-05	0.025	CbGeAlD
Fluoxetine—HTR2C—head—skin cancer	3.57e-05	0.023	CbGeAlD
Fluoxetine—SLC6A2—female reproductive system—skin cancer	3.57e-05	0.0229	CbGeAlD
Fluoxetine—SLC6A4—head—skin cancer	3.39e-05	0.0218	CbGeAlD
Fluoxetine—CYP2B6—skin of body—skin cancer	3.37e-05	0.0216	CbGeAlD
Fluoxetine—HTR2A—connective tissue—skin cancer	3.04e-05	0.0196	CbGeAlD
Fluoxetine—SLC6A2—head—skin cancer	2.98e-05	0.0192	CbGeAlD
Fluoxetine—HTR2A—epithelium—skin cancer	2.89e-05	0.0186	CbGeAlD
Fluoxetine—ORM1—lymph node—skin cancer	2.78e-05	0.0179	CbGeAlD
Fluoxetine—CYP2B6—lymphoid tissue—skin cancer	2.73e-05	0.0175	CbGeAlD
Fluoxetine—CYP2B6—female reproductive system—skin cancer	2.63e-05	0.0169	CbGeAlD
Fluoxetine—CYP2C9—female reproductive system—skin cancer	2.61e-05	0.0167	CbGeAlD
Fluoxetine—ALB—lymph node—skin cancer	2.44e-05	0.0157	CbGeAlD
Fluoxetine—SIGMAR1—lymph node—skin cancer	2.36e-05	0.0151	CbGeAlD
Fluoxetine—CYP2B6—head—skin cancer	2.2e-05	0.0141	CbGeAlD
Fluoxetine—HTR2A—female reproductive system—skin cancer	2.15e-05	0.0138	CbGeAlD
Fluoxetine—SLC6A2—lymph node—skin cancer	2.09e-05	0.0134	CbGeAlD
Fluoxetine—CYP3A4—female reproductive system—skin cancer	1.99e-05	0.0128	CbGeAlD
Fluoxetine—CYP2D6—female reproductive system—skin cancer	1.96e-05	0.0126	CbGeAlD
Fluoxetine—ABCB1—epithelium—skin cancer	1.89e-05	0.0122	CbGeAlD
Fluoxetine—HTR2A—head—skin cancer	1.79e-05	0.0115	CbGeAlD
Fluoxetine—ABCB1—mammalian vulva—skin cancer	1.64e-05	0.0106	CbGeAlD
Fluoxetine—CYP2D6—head—skin cancer	1.63e-05	0.0105	CbGeAlD
Fluoxetine—ABCB1—lymphoid tissue—skin cancer	1.46e-05	0.00937	CbGeAlD
Fluoxetine—ABCB1—female reproductive system—skin cancer	1.41e-05	0.00904	CbGeAlD
Fluoxetine—ABCB1—head—skin cancer	1.17e-05	0.00755	CbGeAlD
Fluoxetine—ABCB1—lymph node—skin cancer	8.23e-06	0.00529	CbGeAlD
